Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2021-05-07

View Filing

D - Notice of Exempt Offering of Securities

Form Type: D

Filing Date: 2021-04-28

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2021-04-27

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2021-04-21

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2021-04-12

View Filing

424B5 - Prospectus [Rule 424(b)(5)]

Form Type: 424B5

Filing Date: 2021-04-12

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2021-04-06

View Filing

PRE 14A - Other preliminary proxy statements

Form Type: PRE 14A

Filing Date: 2021-04-02

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2021-03-30

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2021-03-16

View Filing